Logo
International Journal of
Research in Pharmacy and Pharmaceutical Sciences
ARCHIVES
VOL. 9, ISSUE 1 (2024)
Atorvastatin and ezetimibe protect against hypercholesterolemia: An overview
Authors
Madhuri Lode, Rama Rao Tadikonda, Narender Boggula
Abstract
High blood levels of triglycerides (fats) and cholesterol are treated with a combination of atorvastatin and ezetimibe in conjunction with a balanced diet. This medication may aid in the prevention of illnesses (such as heart attacks and strokes) brought on by blocked blood arteries. HMG-CoA reductase inhibitors, or statins, include atorvastatin and ezetimibe, which both limit the absorption of cholesterol. Both the amount of cholesterol your body produces and absorbs from food will be decreased by these medications. This article explains the various analytical techniques that have been developed and validated in accordance with ICH guidelines for the determination of atorvastatin and ezetimibe. This review describes the drugs like atorvastatin and ezetimibe description, pharmacodynamics, pharmacokinetics, and toxicity. These techniques include UV-Spectrophotometry, Ultra Performance Liquid Chromatography (UPLC), Mass spectrometric, Liquid chromatography-Mass spectroscopy (LC-MS). It is crucial to analyze the drug content and purity percentage in bulk and pharmaceutical formulations for quality control purposes.
Pages:67-71
How to cite this article:
Madhuri Lode, Rama Rao Tadikonda, Narender Boggula "Atorvastatin and ezetimibe protect against hypercholesterolemia: An overview". International Journal of Research in Pharmacy and Pharmaceutical Sciences, Vol 9, Issue 1, 2024, Pages 67-71
Download Author Certificate

Please enter the email address corresponding to this article submission to download your certificate.